RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+14.22%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$949M
AUM Growth
+$949M
(+4.1%)
Cap. Flow
-$29.1M
Cap. Flow
% of AUM
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
31.29%
Holding
98
New
10
Increased
21
Reduced
41
Closed
15
Top Buys
| 1 |
Eli Lilly
LLY
|
$38M |
| 2 |
Zimmer Biomet
ZBH
|
$20.1M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.4M |
| 4 |
Intuitive Surgical
ISRG
|
$11.6M |
| 5 |
Procept Biorobotics
PRCT
|
$9.86M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$21.1M |
| 2 |
Tenet Healthcare
THC
|
$9.77M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$9.44M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$8.61M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$8.33M |
Sector Composition
| 1 | Healthcare | 99.42% |
| 2 | Industrials | 0.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alignment Healthcare
ALHC
$3.23B
| $5.75M | 0.61% |
1,000,000
| – | – |
|
52
Xencor
XNCR
$594M
| $5.62M | 0.59% |
225,000
-25,000
| -10% | -$624K |
|
|
RCM
53
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.54M | 0.58% |
300,000
| – | – |
|
54
Moderna
MRNA
$9.36B
| $5.47M | 0.58% |
+45,000
| New | +$5.47M |
|
55
Immunocore
IMCR
$1.78B
| $5.35M | 0.56% |
89,278
-42,010
| -32% | -$2.52M |
|
|
MRTX
56
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.06M | 0.53% |
140,000
-75,000
| -35% | -$2.71M |
|
57
Inspire Medical Systems
INSP
$2.53B
| $5M | 0.53% |
15,400
-22,992
| -60% | -$7.46M |
|
58
Royalty Pharma
RPRX
$15.8B
| $4.61M | 0.49% |
150,000
-15,000
| -9% | -$461K |
|
59
Evolent Health
EVH
$1.11B
| $4.39M | 0.46% |
+145,000
| New | +$4.39M |
|
60
Health Catalyst
HCAT
$228M
| $4M | 0.42% |
320,000
-20,000
| -6% | -$250K |
|
61
Bio-Techne
TECH
$8.3B
| $3.88M | 0.41% |
47,500
-7,500
| -14% | -$612K |
|
62
Neurocrine Biosciences
NBIX
$13.5B
| $3.77M | 0.4% |
40,000
-30,000
| -43% | -$2.83M |
|
63
Nuvalent
NUVL
$5.74B
| $3.63M | 0.38% |
86,011
-13,989
| -14% | -$590K |
|
64
MeiraGTx Holdings
MGTX
$590M
| $3.62M | 0.38% |
538,986
| – | – |
|
65
West Pharmaceutical
WST
$17.9B
| $3.44M | 0.36% |
9,000
-6,000
| -40% | -$2.29M |
|
|
RVNC
66
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.11M | 0.33% |
123,000
-107,000
| -47% | -$2.71M |
|
|
OLK
67
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $3.11M | 0.33% |
166,000
-8,300
| -5% | -$156K |
|
68
Viking Therapeutics
VKTX
$3.02B
| $2.92M | 0.31% |
180,000
| – | – |
|
69
Axsome Therapeutics
AXSM
$6.09B
| $2.88M | 0.3% |
40,100
+25,100
| +167% | +$1.8M |
|
70
Edwards Lifesciences
EW
$47.7B
| $2.74M | 0.29% |
29,000
-41,000
| -59% | -$3.87M |
|
71
Relay Therapeutics
RLAY
$709M
| $2.39M | 0.25% |
190,000
| – | – |
|
72
BridgeBio Pharma
BBIO
$9.91B
| $2.32M | 0.24% |
135,000
| – | – |
|
73
Arvinas
ARVN
$580M
| $2.11M | 0.22% |
85,000
| – | – |
|
74
Intellia Therapeutics
NTLA
$1.26B
| $2.04M | 0.21% |
50,000
| – | – |
|
75
Immunovant
IMVT
$2.91B
| $1.9M | 0.2% |
+100,000
| New | +$1.9M |
|